Wolfson School of Mechanical & Manufacturing Engineering, Loughborough University, Loughborough LE11 3TU, UK.
Biotechnol Bioeng. 2010 Mar 1;105(4):842-53. doi: 10.1002/bit.22581.
In this work a new phenomenological model of growth of cartilage tissue cultured in a rotating bioreactor is developed. It represents an advancement of a previously derived model of deposition of glycosaminoglycan (GAG) in engineered cartilage by (i) introduction of physiological mechanisms of proteoglycan accumulation in the extracellular matrix (ECM) as well as by correlating (ii) local cell densities and (iii) tissue growth to the ECM composition. In particular, previously established predictions and correlations of local oxygen concentrations and GAG synthesis rates are extended to distinguish cell secreted proteoglycan monomers free to diffuse in cell surroundings and outside from the engineered construct, from large aggrecan molecules, which are constrained within the ECM and practically immovable. The model includes kinetics of aggregation, that is, transformation of mobile GAG species into immobile aggregates as well as maintenance of the normal ECM composition after the physiological GAG concentration is reached by incorporation of a product inhibition term. The model also includes mechanisms of the temporal evolution of cell density distributions and tissue growth under in vitro conditions. After a short initial proliferation phase the total cell number in the construct remains constant, but the local cell distribution is leveled out by GAG accumulation and repulsion due to negative molecular charges. Furthermore, strong repulsive forces result in expansion of the local tissue elements observed macroscopically as tissue growth (i.e., construct enlargement). The model is validated by comparison with experimental data of (i) GAG distribution and leakage, (ii) spatial-temporal distributions of cells, and (iii) tissue growth reported in previous works. Validation of the model predictive capability--against a selection of measured data that were not used to construct the model--suggests that the model successfully describes the interplay of several simultaneous processes carried out during in vitro cartilage tissue regeneration and indicates that this approach could also be attractive for application in other tissue engineering systems.
在这项工作中,开发了一种新的旋转生物反应器中培养的软骨组织生长的现象学模型。它代表了以前推导的工程软骨中糖胺聚糖(GAG)沉积模型的改进,方法是(i)引入蛋白聚糖在细胞外基质(ECM)中的积累的生理机制,以及通过(ii)局部细胞密度和(iii)组织生长与 ECM 组成相关联。特别是,以前建立的局部氧浓度和 GAG 合成速率的预测和相关性被扩展到区分细胞分泌的可在细胞周围和细胞外自由扩散的蛋白聚糖单体与被限制在 ECM 内且几乎不可移动的大聚集蛋白聚糖分子。该模型包括聚集动力学,即可扩散的 GAG 物种向不可移动的聚集物的转化,以及通过引入产物抑制项来维持生理 GAG 浓度后 ECM 组成的正常维持。该模型还包括在体外条件下细胞密度分布和组织生长的时间演变机制。在初始短暂增殖阶段之后,构建体中的总细胞数保持不变,但是由于负分子电荷引起的 GAG 积累和排斥,局部细胞分布得到平衡。此外,强大的排斥力导致局部组织元素的扩张,这在宏观上表现为组织生长(即构建体扩大)。通过与(i)GAG 分布和泄漏,(ii)细胞的时空分布以及(iii)以前的工作中报道的组织生长的实验数据进行比较来验证模型。对未用于构建模型的选定测量数据的模型预测能力的验证表明,该模型成功地描述了体外软骨组织再生过程中同时进行的几个过程的相互作用,并表明该方法也可能适用于其他组织工程系统。